Many studies on MYBL2, E2F7, CCN4, and MET genes promote tumor progression by promoting tumor proliferation, differentiation, and migration [10, 33–35], which may also contribute to the malignant progression of IDH-mutant astrocytoma. This evidence concerns the gene MET and astrocytoma (excluding glioblastoma).